Testimonials

Client Testimonials for Our Clinical Research Solution

Luma Melo

We unified our clinical research workflows enterprise-wide using Jeeva, enabling our small team to efficiently manage all studies with highly responsive support. We are saving 60% time effort across all clinical trials.

Luma Melo, PhD, MSc, MBA, MA

Taxa technologies

Jeeva gave us exactly the configurations we needed for our Pivotal clinical trials. I appreciate the functionality of the system.

Mihaela Plesa, BA, CCRP

Director of Research Projects at Frantz Viral Therapeutics

Frank Sasinowski

There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.

Frank Sasinowski, JD, MPH

A Legendary Leader in Rare Diseases and Orphan Drugs Regulation

Sean Mallon

We are pleased to provide financial support - both in the form of a grant and an equity investment - to Jeeva. Jeeva is an excellent example of the kind of startup we look to support and pursuing an enormous market opportunity. We wish Dr. Rajasimha and his team the best of luck as they continue to build this company.

Sean Mallon

Vice President, Virginia Innovation Partnership Corporation (VIPC)

Christiaan Engstrom

Jeeva is a leader in the clinical trials software industry, with faster patient recruitment, focusing on global patient engagement.

Christiaan Engstrom

Founder, Bullpen Club

Lawrence Cheskin

Jeeva is backed by excellent customer service. We are enjoying our seamless transition to this platform for our longitudinal cohort study. Flexibility in programming.

Dr. Lawrence Cheskin, MD

Professor and Chair, Nutrition and Food Studies, George Mason University

Sunil Tadepalli, MD

Together, we can significantly reduce trial timelines and improve patient outcomes across key therapeutic areas.

Sunil Tadepalli, MD

CEO, Labnetworx

Gurudath Gurjal

We are thrilled to partner with Jeeva to bring next-generation efficiencies to clinical research. The need for AI-driven automation in clinical trials has never been greater, and a unified CTMS approach is exactly what the industry needs

Gurudath Gurjal, MSc

Director, ClinTrek

Luma Melo, PhD, MSc, MBA, MA

Taxa technologies

Mihaela Plesa, BA, CCRP

Director of Research Projects at Frantz Viral Therapeutics

Dr Terry jo Bichell Image

We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders

Dr. Terry Jo Bichell

CombinedBrain

David Hirsch

Jeeva is a best-in-class solution for gathering clinical information with best-in-class customer service—two thumbs up.

David Hirsch

Founder, Special Father's Network, 21st Century Dads Foundation

Nisha Venugopal

Jeeva's easy-to-use software interfaces and detailed user manual are backed by outstanding support team! Jeeva's technology platform enables us to serve patients globally in their native language.

Nisha Venugopal, Ph.D

Associate Director, Patient Focused Research Programs, Indo US Organization for Rare Diseases

Rahul Purwar

Jeeva platform & service is aligned with our vision to making CAR-T cell therapies affordable in emerging markets.

Rahul Purwar

Founder at ImmunoACT

Robert Freishtat, MD

Rare disease trials are already complex enough without the added burden of fragmented trial management. Jeeva’s AI-powered CTMS offers a way to streamline operations and ensure regulatory compliance.”

Robert Freishtat, MD

President of Uncommon Cures

Veronica Bubb, PhD

President & Principal Biostatistical Consultant ALTRU Clinical Research

Dr. Emmanuel Gorospe

In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial.

Dr. Emmanuel Gorospe

Chief Medical Officer of KCRS

Shirish Arya

We need to bring healthcare and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the correct value-for-money proposition without compromising quality.

Shirish Arya

Director of Strategy at ImmunoACT

Josh Green

We are proud that Jeeva emerged as #1 on the National Science Foundation (NSF) Innovation-Corps Program leaderboard.

Josh Green, PMP

Director ICAP, Small Business Development Center, George Mason University

Marshall Summar, MD, Ph.D

Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.

Marshall Summar, MD, Ph.D

CEO, Uncommon Cures LLC

Kimberly Chapman

Jeeva's simple and elegant video consenting solution saves me hundreds of hours of repetitive process of obtaining informed consent from study participants

Kimberly Chapman, MD, Ph.D.

Principal Investigator, Childrens National Medical Center

Sara Tylosky

Having evaluated numerous clinical trial platforms, Jeeva was refreshing in its vision to engage underrepresented minorities, focus on rare diseases, and collaborative approach beyond technology. We are eager to enable patient education, recruitment, and retention in rare disease clinical studies such as patient registries and cell/gene therapies.

Sara Tylosky, CEO

CEO, Farmacon Global

Luma Melo

We unified our clinical research workflows enterprise-wide using Jeeva, enabling our small team to efficiently manage all studies with highly responsive support. We are saving 60% time effort across all clinical trials.

Luma Melo, PhD, MSc, MBA, MA

Taxa technologies

Luma Melo, PhD, MSc, MBA, MA

Taxa technologies

Veronica Bubb, PhD

President & Principal Biostatistical Consultant ALTRU Clinical Research

Jeeva gave us exactly the configurations we needed for our Pivotal clinical trials. I appreciate the functionality of the system.

Mihaela Plesa, BA, CCRP

Director of Research Projects at Frantz Viral Therapeutics

Mihaela Plesa, BA, CCRP

Director of Research Projects at Frantz Viral Therapeutics

Dr. Emmanuel Gorospe

In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial.

Dr. Emmanuel Gorospe

Chief Medical Officer of KCRS

Frank Sasinowski

There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.

Frank Sasinowski, JD, MPH

A Legendary Leader in Rare Diseases and Orphan Drugs Regulation

Dr Terry jo Bichell Image

We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders

Dr. Terry Jo Bichell

CombinedBrain

Shirish Arya

We need to bring healthcare and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the correct value-for-money proposition without compromising quality.

Shirish Arya

Director of Strategy at ImmunoACT

Sean Mallon

We are pleased to provide financial support - both in the form of a grant and an equity investment - to Jeeva. Jeeva is an excellent example of the kind of startup we look to support and pursuing an enormous market opportunity. We wish Dr. Rajasimha and his team the best of luck as they continue to build this company.

Sean Mallon

Vice President, Virginia Innovation Partnership Corporation (VIPC)

David Hirsch

Jeeva is a best-in-class solution for gathering clinical information with best-in-class customer service—two thumbs up.

David Hirsch

Founder, Special Father's Network, 21st Century Dads Foundation

Josh Green

We are proud that Jeeva emerged as #1 on the National Science Foundation (NSF) Innovation-Corps Program leaderboard.

Josh Green, PMP

Director ICAP, Small Business Development Center, George Mason University

Christiaan Engstrom

Jeeva is a leader in the clinical trials software industry, with faster patient recruitment, focusing on global patient engagement.

Christiaan Engstrom

Founder, Bullpen Club

Nisha Venugopal

Jeeva's easy-to-use software interfaces and detailed user manual are backed by outstanding support team! Jeeva's technology platform enables us to serve patients globally in their native language.

Nisha Venugopal, Ph.D

Associate Director, Patient Focused Research Programs, Indo US Organization for Rare Diseases

Marshall Summar, MD, Ph.D

Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.

Marshall Summar, MD, Ph.D

CEO, Uncommon Cures LLC

Lawrence Cheskin

Jeeva is backed by excellent customer service. We are enjoying our seamless transition to this platform for our longitudinal cohort study. Flexibility in programming.

Dr. Lawrence Cheskin, MD

Professor and Chair, Nutrition and Food Studies, George Mason University

Rahul Purwar

Jeeva platform & service is aligned with our vision to making CAR-T cell therapies affordable in emerging markets.

Rahul Purwar

Founder at ImmunoACT

Kimberly Chapman

Jeeva's simple and elegant video consenting solution saves me hundreds of hours of repetitive process of obtaining informed consent from study participants

Kimberly Chapman, MD, Ph.D.

Principal Investigator, Childrens National Medical Center

Sunil Tadepalli, MD

Together, we can significantly reduce trial timelines and improve patient outcomes across key therapeutic areas.

Sunil Tadepalli, MD

CEO, Labnetworx

Robert Freishtat, MD

Rare disease trials are already complex enough without the added burden of fragmented trial management. Jeeva’s AI-powered CTMS offers a way to streamline operations and ensure regulatory compliance.”

Robert Freishtat, MD

President of Uncommon Cures

Sara Tylosky

Having evaluated numerous clinical trial platforms, Jeeva was refreshing in its vision to engage underrepresented minorities, focus on rare diseases, and collaborative approach beyond technology. We are eager to enable patient education, recruitment, and retention in rare disease clinical studies such as patient registries and cell/gene therapies.

Sara Tylosky, CEO

CEO, Farmacon Global

Gurudath Gurjal

We are thrilled to partner with Jeeva to bring next-generation efficiencies to clinical research. The need for AI-driven automation in clinical trials has never been greater, and a unified CTMS approach is exactly what the industry needs

Gurudath Gurjal, MSc

Director, ClinTrek

Luma Melo

We unified our clinical research workflows enterprise-wide using Jeeva, enabling our small team to efficiently manage all studies with highly responsive support. We are saving 60% time effort across all clinical trials.

Luma Melo, PhD, MSc, MBA, MA

Taxa technologies

Veronica Bubb, PhD

President & Principal Biostatistical Consultant ALTRU Clinical Research

Mihaela Plesa, BA, CCRP

Director of Research Projects at Frantz Viral Therapeutics

Frank Sasinowski

There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.

Frank Sasinowski, JD, MPH

A Legendary Leader in Rare Diseases and Orphan Drugs Regulation

Shirish Arya

We need to bring healthcare and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the correct value-for-money proposition without compromising quality.

Shirish Arya

Director of Strategy at ImmunoACT

David Hirsch

Jeeva is a best-in-class solution for gathering clinical information with best-in-class customer service—two thumbs up.

David Hirsch

Founder, Special Father's Network, 21st Century Dads Foundation

Christiaan Engstrom

Jeeva is a leader in the clinical trials software industry, with faster patient recruitment, focusing on global patient engagement.

Christiaan Engstrom

Founder, Bullpen Club

Marshall Summar, MD, Ph.D

Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.

Marshall Summar, MD, Ph.D

CEO, Uncommon Cures LLC

Rahul Purwar

Jeeva platform & service is aligned with our vision to making CAR-T cell therapies affordable in emerging markets.

Rahul Purwar

Founder at ImmunoACT

Sunil Tadepalli, MD

Together, we can significantly reduce trial timelines and improve patient outcomes across key therapeutic areas.

Sunil Tadepalli, MD

CEO, Labnetworx

Sara Tylosky

Having evaluated numerous clinical trial platforms, Jeeva was refreshing in its vision to engage underrepresented minorities, focus on rare diseases, and collaborative approach beyond technology. We are eager to enable patient education, recruitment, and retention in rare disease clinical studies such as patient registries and cell/gene therapies.

Sara Tylosky, CEO

CEO, Farmacon Global

Luma Melo, PhD, MSc, MBA, MA

Taxa technologies

Jeeva gave us exactly the configurations we needed for our Pivotal clinical trials. I appreciate the functionality of the system.

Mihaela Plesa, BA, CCRP

Director of Research Projects at Frantz Viral Therapeutics

Dr. Emmanuel Gorospe

In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial.

Dr. Emmanuel Gorospe

Chief Medical Officer of KCRS

Dr Terry jo Bichell Image

We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders

Dr. Terry Jo Bichell

CombinedBrain

Sean Mallon

We are pleased to provide financial support - both in the form of a grant and an equity investment - to Jeeva. Jeeva is an excellent example of the kind of startup we look to support and pursuing an enormous market opportunity. We wish Dr. Rajasimha and his team the best of luck as they continue to build this company.

Sean Mallon

Vice President, Virginia Innovation Partnership Corporation (VIPC)

Josh Green

We are proud that Jeeva emerged as #1 on the National Science Foundation (NSF) Innovation-Corps Program leaderboard.

Josh Green, PMP

Director ICAP, Small Business Development Center, George Mason University

Nisha Venugopal

Jeeva's easy-to-use software interfaces and detailed user manual are backed by outstanding support team! Jeeva's technology platform enables us to serve patients globally in their native language.

Nisha Venugopal, Ph.D

Associate Director, Patient Focused Research Programs, Indo US Organization for Rare Diseases

Lawrence Cheskin

Jeeva is backed by excellent customer service. We are enjoying our seamless transition to this platform for our longitudinal cohort study. Flexibility in programming.

Dr. Lawrence Cheskin, MD

Professor and Chair, Nutrition and Food Studies, George Mason University

Kimberly Chapman

Jeeva's simple and elegant video consenting solution saves me hundreds of hours of repetitive process of obtaining informed consent from study participants

Kimberly Chapman, MD, Ph.D.

Principal Investigator, Childrens National Medical Center

Robert Freishtat, MD

Rare disease trials are already complex enough without the added burden of fragmented trial management. Jeeva’s AI-powered CTMS offers a way to streamline operations and ensure regulatory compliance.”

Robert Freishtat, MD

President of Uncommon Cures

Gurudath Gurjal

We are thrilled to partner with Jeeva to bring next-generation efficiencies to clinical research. The need for AI-driven automation in clinical trials has never been greater, and a unified CTMS approach is exactly what the industry needs

Gurudath Gurjal, MSc

Director, ClinTrek